<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>FULLIFE - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/203909.xml</link>
<description>FULLIFE - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>Diabetic Climber Conquers Mt. Everest</title>
     <link>http://www.prweb.com/releases/2006/10/prweb464422.htm</link><description>   <![CDATA[ <P>Type-1 diabetic Geri Winkler completed the ascent to the top of Mt. Everest on the way to being the first diabetic to climb the world&#039;s Seven Summits. Geri&#039;s latest success on Mt. Everest makes this the fifth and tallest of the seven summits he has dedicated himself to climbing to prove to the world that diabetics can achieve a full active live. (PRWeb Oct 29, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/10/prweb464422.htm">http://www.prweb.com/releases/2006/10/prweb464422.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/10/prweb464422.htm</guid>
        </item>
<item>
     <title>Treating Diabetes with Bitter Melon in the Philippines</title>
     <link>http://www.prweb.com/releases/2006/08/prweb422962.htm</link><description>   <![CDATA[ <P>In the Philippines the Department of Health is promoting bitter melon, locally called ampalaya, as a treatment for adult-onset diabetes in the form of a tea-like drink made by boiling its unripe fruits of young leaves.  The ampalaya&#8217;s active ingredient polypeptide P, momordicin, and charantin - are most concentrated in the fruit and seeds. (PRWeb Aug 21, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/08/prweb422962.htm">http://www.prweb.com/releases/2006/08/prweb422962.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/08/prweb422962.htm</guid>
        </item>
</channel>
</rss>